CDK12 and neoplasm: While the whole-chromosome LOH allows a nascent tumor to expunge the remaining wild-type TP53, the same mechanism may also contribute to the biallelic inactivation or reduced dosage of other tumor suppressor genes in the same chromosome, such as CDK12, BRCA1, BRIP1, and NF1 [23, 57].